Outdated Prescription Drug Labeling: How FDA-Approved Prescribing Information Lags Behind Real-World Clinical Practice. (Record no. 28345419)
[ view plain ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 01278 a2200349 4500 |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20250517213537.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 201904s 0 0 eng d |
| 022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
| International Standard Serial Number | 2168-4804 |
| 024 7# - OTHER STANDARD IDENTIFIER | |
| Standard number or code | 10.1177/2168479018759662 |
| Source of number or code | doi |
| 040 ## - CATALOGING SOURCE | |
| Original cataloging agency | NLM |
| Language of cataloging | eng |
| Transcribing agency | NLM |
| 100 1# - MAIN ENTRY--PERSONAL NAME | |
| Personal name | Shea, Michael B |
| 264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
| Date of production, publication, distribution, manufacture, or copyright notice | 20190416 |
| 245 00 - TITLE STATEMENT | |
| Title | Outdated Prescription Drug Labeling: How FDA-Approved Prescribing Information Lags Behind Real-World Clinical Practice. |
| Medium | [electronic resource] |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
| Name of publisher, distributor, etc. | Therapeutic innovation & regulatory science |
| Date of publication, distribution, etc. | 11 2018 |
| 300 ## - PHYSICAL DESCRIPTION | |
| Extent | 771-777 p. |
| Other physical details | digital |
| 500 ## - GENERAL NOTE | |
| General note | Publication Type: Comparative Study; Journal Article |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Antineoplastic Agents |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Drug Labeling |
| General subdivision | standards |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Drug Utilization |
| General subdivision | standards |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Humans |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Off-Label Use |
| General subdivision | standards |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Prescription Drugs |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | United States |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | United States Food and Drug Administration |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Stewart, Mark |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Van Dyke, Hugo |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Ostermann, Linda |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Allen, Jeff |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Sigal, Ellen |
| 773 0# - HOST ITEM ENTRY | |
| Title | Therapeutic innovation & regulatory science |
| Related parts | vol. 52 |
| -- | no. 6 |
| -- | p. 771-777 |
| 856 40 - ELECTRONIC LOCATION AND ACCESS | |
| Uniform Resource Identifier | <a href="https://doi.org/10.1177/2168479018759662">https://doi.org/10.1177/2168479018759662</a> |
| Public note | Available from publisher's website |
No items available.